Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
15.67
0.00 (0.00%)
At close: Jul 8, 2026, 4:00 PM EDT
15.64
-0.03 (-0.19%)
After-hours: Jul 8, 2026, 6:14 PM EDT
Rallybio Employees
Rallybio had 9 employees as of March 31, 2026. The number of employees decreased by 15 or -62.50% compared to the same quarter last year.
Employees
9
Change
-15
Growth
-62.50%
Revenue / Employee
$95,333
Profits / Employee
-$868,556
Market Cap
83.02M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 9 | -15 | -62.50% |
| Dec 31, 2025 | 14 | -11 | -44.00% |
| Sep 30, 2025 | 15 | -10 | -40.00% |
| Jun 30, 2025 | 20 | -5 | -20.00% |
| Mar 31, 2025 | 24 | -6 | -20.00% |
| Dec 31, 2024 | 25 | -18 | -41.86% |
| Sep 30, 2024 | 25 | -19 | -43.18% |
| Jun 30, 2024 | 25 | -20 | -44.44% |
| Mar 31, 2024 | 30 | -13 | -30.23% |
| Dec 31, 2023 | 43 | 2 | 4.88% |
| Sep 30, 2023 | 44 | 0 | - |
| Jun 30, 2023 | 45 | 0 | - |
| Mar 31, 2023 | 43 | 3 | 7.50% |
| Dec 31, 2022 | 41 | 6 | 17.14% |
| Sep 30, 2022 | 44 | 13 | 41.94% |
| Jun 30, 2022 | 45 | 17 | 60.71% |
| Mar 31, 2022 | 40 | 12 | 42.86% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 213 |
| Gossamer Bio | 162 |
| Heron Therapeutics | 128 |
| Pelthos Therapeutics | 92 |
| Acrivon Therapeutics | 76 |
| Rani Therapeutics Holdings | 71 |
| Cardiff Oncology | 31 |
| Entera Bio | 22 |
RLYB News
- 5 weeks ago - Rallybio to acquire Avenzo Therapeutics through merger transaction - TheFly
- 5 weeks ago - Rallybio Transcript: M&A announcement - Transcripts
- 5 weeks ago - Rallybio Press release: M&A announcement - Filings
- 5 weeks ago - Rallybio Corporation and Avenzo Therapeutics Announce Merger Agreement to Advance Next-Generation Oncology Therapies and $215 Million Concurrent Private Placement - Business Wire
- 4 months ago - Rallybio Annual report: Q4 2025 - Filings
- 4 months ago - Rallybio, Candid Therapeutics announce merger agreement - TheFly
- 4 months ago - Rallybio Transcript: M&A announcement - Transcripts
- 4 months ago - Rallybio Press release: M&A announcement - Filings